Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome

INTRODUCTION: Polo-like kinase-1 (PLK1) is a crucial driver of cell cycle progression and its down-regulation plays an important checkpoint role in response to DNA damage. Mechanistically, this is mediated by p53 which represses PLK1 expression through chromatin remodelling. Consistent with this mod...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Sharon I, Purdie, Colin A, Bray, Susan E, Quinlan, Philip R, Jordan, Lee B, Thompson, Alastair M, Meek, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446374/
https://www.ncbi.nlm.nih.gov/pubmed/22405092
http://dx.doi.org/10.1186/bcr3136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446374/
https://www.ncbi.nlm.nih.gov/pubmed/22405092
http://dx.doi.org/10.1186/bcr3136

Ejemplares similares